Diabetes Research and Clinical Practice
Volume 58, Issue 3 , Pages 179-185, December 2002

Endothelial nitric oxide synthase gene and the development of diabetic nephropathy

  • Tomoaki Shimizu

      Affiliations

    • Department of Medicine, Metabolism and Endocrinology, Juntendo University School of Medicine, Hongo 3-1-1, Bunkyo, Zip# 113-8421 Tokyo, Japan
  • ,
  • Tomio Onuma

      Affiliations

    • Department of Medicine, Metabolism and Endocrinology, Juntendo University School of Medicine, Hongo 3-1-1, Bunkyo, Zip# 113-8421 Tokyo, Japan
    • Corresponding Author InformationCorresponding author. Tel.: +81-3-3813-3111x3560; fax: +81-3-3813-5996
  • ,
  • Ryuzo Kawamori

      Affiliations

    • Department of Medicine, Metabolism and Endocrinology, Juntendo University School of Medicine, Hongo 3-1-1, Bunkyo, Zip# 113-8421 Tokyo, Japan
  • ,
  • Yuichiro Makita

      Affiliations

    • Department of Medicine, Divison of Nephrology, Juntendo University School of Medicine, Hongo 3-1-1, Bukyo, Tokyo, Japan
  • ,
  • Yasuhiko Tomino

      Affiliations

    • Department of Medicine, Divison of Nephrology, Juntendo University School of Medicine, Hongo 3-1-1, Bukyo, Tokyo, Japan

Received 3 October 2001; received in revised form 8 May 2002; accepted 17 June 2002.

Abstract 

Background: Endothelial nitric oxide synthase gene and the development of diabetic nephropathy Background: Intron 4 insertion/deletion polymorphism of the constitutive endothelial nitric oxide synthase (ecNOS) gene may be related to diabetic nephropathy. Methods: A case-control study was performed in three groups of Japanese patients with Type 2 diabetes mellitus, which including 123 patients with advanced diabetic nephropathy, 107 patients with overt proteinuria and normal serum creatinine level, and a control group of 203 patients with normal renal function despite having diabetes for over 10 years. Additionally, logistic regression analysis was used to assess the findings. Results: When we examined the a-deletion/b-insertion in intron 4 of ecNOS gene, the genotype and allele frequencies were not significantly different between the patients with advanced diabetic nephropathy (a/a 2.4, a/b 21.9, b/b 75.5, ‘a’ 13.4, ‘b’ 86.6%), the patients with overt proteinuria (a/a 2.8, a/b 15.8, b/b 81.4, ‘a’ 10.7, ‘b’ 89.3%) and the control group (a/a 1.4, a/b 21.6, b/b 76.8, ‘a’ 12.8, ‘b’ 87.7%). Logistic regression analysis showed that the ecNOS intron4 a-allele frequency was not the related to nephropathy (P=0.88). Conclusion: We conclude that there is no association of the ecNOS gene polymorphism with the development of diabetic nephropathy in Japanese patients with type 2 diabetes.

Keywords:  Constitutive endothelial nitric oxide synthase gene, Diabetic nephropathy, Type 2 diabetes mellitus, Japanese

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0168-8227(02)00156-0

Diabetes Research and Clinical Practice
Volume 58, Issue 3 , Pages 179-185, December 2002